References
- Eur. J. Pharm. v.440 Orlistat:its current status as an anti-obesity drug Ballinger, A.;Peikin, S.I.R. https://doi.org/10.1016/S0014-2999(02)01422-X
- J. Nutr. v.132 The underlying basis for obesity:relationship to cancer Bray, G.A.
- Am. J. Clin. Nutr. v.68 Dietary fat intake does affect obesity Bray, G.A.;Popkin, B.M.
- Am. J. Clin. Nutr. v.70 Dietary fat affects obesity rate Bray, G.A.;Popkin, B.M. https://doi.org/10.1093/ajcn/70.4.572
- Int. J. Obesity v.19 Orlistat (Ro 18-0647), a lipase inhibitor,in the treatment of human obesity:a multiple dose study Drent, M.L.;Larsson, I.;William-Olsson, T.;Quaade, F.;Czubayko, F.;Bergmann, K.;Strobel, W.;Sjostrom, L.;van der Veen, E.A.
- Adv. Drug. Deliv. Rev. v.25 Structure and function of gastrointestinal lipases Embleton, J.K.;Pouton, C.W. https://doi.org/10.1016/S0169-409X(96)00488-7
- JAMA v.288 Prevalence and trends in obesity among US adults,1999-2000 Flegal, K.M.;Carroll, M.D.;Ogden, C.L.;Johnson, C.L. https://doi.org/10.1001/jama.288.14.1723
- Biochimica. et Biophysica. Acta. v.1334 Covalent inhibition of digestive lipases an in vitro study Garugouri, Y.;Ransac, S.;Verger, R.
- J. Lipid Res. v.25 Studies on the inhibition of pancreatic and microbial lipases by soybean proteins Garugouri, Y.;Julien, R.;Pieroni, G.;Verger, R.;Sarda, L.
- Int. J. Obes. Rel. Metab Dis. v.25 Anti-obesity effects in rodents of dietary teasaponin, lipase inhibitor Han, L.K.;Kimura, Y.;Kawashima, M.;Takaku, T.;Taniyama, T.;Hayashi, T.;Zheng, Y.N.;Okuda, H. https://doi.org/10.1038/sj.ijo.0801747
- Phytochemistry v.46 Flavin dimers with lipase inhibitory activity from Cassia nomame Hatano, T.;Yamashita, A.;Hashimoto, T.;Ito, H.;Kubo, N.;Yoshiyama, M.;Shimura, S.;Itoh, Y.;Okuda, T.;Yoshida, T. https://doi.org/10.1016/S0031-9422(97)00367-1
- J. Molecular Catalysis B : Enzymatic. v.22 Lipase inhibitor for the treatment of acne Higaki, S. https://doi.org/10.1016/S1381-1177(03)00053-5
-
J. Nutr. Biochem.
v.11
Green tea extract
$(AR25^{\circledR})$ inhibits lipolysis of triglycerides in gastric and duodenal medium in vitro Juhel, C.;Armand, M.;Pafumi, Y.;Rosier, C.;Vandermander, J.;Lairon, D. https://doi.org/10.1016/S0955-2863(99)00070-4 - Am. J. Physiol. v.266 Control of canine gastric emptying of fat by lipolytic products Meyer, J.H.;Elashoff, J.D.;Domeck, M.;Levy, A.;Jehn, D.;Hlinka, M.;Lake, R.;Graham, L.S.;Gu, Y.G.
- Am. J. Physiol. v.275 Role of small intestine in caloric compensations to oil premeals in rats Meyer, J.H.;Hlinka, M.;Khatibi, A.;Raybould, H.E.;Tso, P.
- Biocatalysis v.5 A new spectrophotometric method for the detection of lipase activity using 2,4-dinitrophenyl butyrate as a substrate Mosmuller, E.W.J.;Van Heemst, J.D.H.;Van Delden, C.J.;Franssen, M.C.R.;Engbersen, J.F.J. https://doi.org/10.3109/10242429209014874
- Am. J. Cardiol. v.87 Effect of Orlistat-Assisted Weight Loss in Decreasing Coronary Heart Disease Risk in Patients with Syndrome X Reaven, G.;Segal, K.;Hauptman, J.;Boldrin, M.;Lucas, C. https://doi.org/10.1016/S0002-9149(00)01521-6
- Biosci. Biotech. Biochem. v.56 Inhibitor Effect on Lipase Activity of Extracts from Medicinal Herbs Shimura, S.;Tsuzuki, W.;Kobayashi, S.;Suzuki, T. https://doi.org/10.1271/bbb.56.1478
- Clin. Nutr. v.21 Degree of in vivo inhibition of human gastric and pancreatic lipases by Orlistat (Tetrahydrolipstatin,THL) in the stomach and small intestine Sternby, B.;Hartmann, D.;Borgsrom, B.;Nilsson, A. https://doi.org/10.1054/clnu.2002.0565
- Int .J. Obes. v.24 Anti-obesity effects of lipase inhibitor CT-II, an extract from edible herbs, Nomame herba, on rats fed a high-fat diet Yamamoto, M.;Shimura, S.;Itoh, Y.;Ohsaka, T.;Egawa, M.;Inoue, S. https://doi.org/10.1038/sj.ijo.0801222
- N. Engl. J. Med. v.346 Obesity Yanovski, S.Z.;Yanovski, J.A. https://doi.org/10.1056/NEJMra012586
- J. Nutr. v.132 Salacia reticulata and its polyphenolic constituents with lipase inhibitory and lipolytic activities have mild antiobesity effects in rats Yoshikawa, M.;Shimoda, H.;Nishida, N.;Takada, M.;Matsuda, H.